CLINICAL ROLE -
FDA Introduces New Options for Patients in Observance of Rare Disease Day
Several new approaches may increase drug development efforts for rare diseases.
Read More
Clinical Trial Shows Efficacy of Rare Disease Treatment
The data published analyzes findings from key studies evaluating taliglucerase alfa in patients with Gaucher disease.
Trending News Today: Bipartisan Senators Seek More Resources for Fight Against Opioid Epidemic
Top news of the day from across the health care landscape.
New NCCN Guidelines Address HIV Infection Among Patients With Cancer
The National Comprehensive Cancer Network seeks to address issues related to treating HIV-positive patients with cancer, such as the potential for drug interactions.
Guidelines Discuss Treatment Options for Patients with HIV, Cancer
Pharmacy Food Hacks: How to Find the Best Food Sold in Pharmacies
There are a lot of options for food items sold in your pharmacy—here is a simple guide to help you pick the very best.
Pharmacy Times, Specialty Pharmacy Times Launch Pharmacist Feature Friday
Pharmacists can submit photos and captions to be featured on social media.
Specialty Pharmacy Times, Pharmacy Times Launch Pharmacist Feature Friday
States Take Action Against Prescription Drug Spending in Medicaid
Medicaid spending on specialty drugs is a top concern for states.
Omega 3 Fish Oils Have Anti-Colon Cancer Properties
Benefits of fish oils may be reduced in obese patients due to high inflammation levels.
Treating Depression May Lead to Better HIV Outcomes
Number of days spent depressed resulted in higher mortality rates among patients with HIV.
Study: Testing All Adults for Hepatitis C Virus is Cost-Effective
Targeting all adults for hepatitis C virus testing may identify more cases and improve cure rates.
Sedentary Lifestyle Causes Risk of Lung, Head and Neck Cancers to Skyrocket
Increasing exercise levels may reduce the risk of several cancers.
Out-of-Pocket Costs Increase for Patients with Multiple Chronic Diseases
As cost increases, patient adherence decreases among patients with multiple chronic conditions.
Trending News Today: States Sue Federal Government to End Affordable Care Act
Trending News Today: More States Seeking Oversight of Compounding Pharmacies
Short-Term Health Plans Projected to Increase Premiums
Last week, the Trump administration proposed extending the time Americans can stay in short-term plans from 3 months to 12 months.
A Patient Guide to Gluten-free Living
Helping patients find healthy and safe alternatives is key to supporting them with living a healthy lifestyle and decreasing gastrointestinal symptoms, fatigue and inflammation associated with celiac disease.
FDA Expands Abemaciclib Indication as Initial Therapy for Advanced Breast Cancer
The FDA previously approved abemaciclib for use in combination with fulvestrant in women with HR+/HER2- advanced breast cancer with disease progression following endocrine therapy.
Progress Continues in Developing Alternative Payment Models
The standardization of value-based models is crucial as they become widely-adopted.
New Study Explores Potential of Mediterranean Diet in Multiple Sclerosis
The gut microbiome may play a key role impact the severity of multiple sclerosis symptoms.
Registration Open for the 2018 NASP Annual Meeting
The sixth annual National Association of Specialty Pharmacy meeting features numerous educational sessions and networking opportunities for specialty pharmacy stakeholders.
Placebo Reduces Fatigue in Cancer Survivors
Patients with cancer experienced a reduction in fatigue after 3 weeks of knowingly taking a placebo.
Organ-on-Chip Technology Simulates Human Reaction to Hepatitis B Virus
An artificial liver infected with hepatitis B demonstrates physiological reaction of a real human liver.
Self-Testing for Cervical Cancer May Remove Screening Barriers
Some patients may be unwilling to undergo traditional screening for cervical cancer.
Trending News Today: Democrats Moving Towards Single-Payer Health Care System
Trending News Today: FDA Sets Framework to Increase Access to Opioid Use Disorder Treatments
Risk-Adjustment Reimbursement May Fall Short in Some Cases
Risk adjustment must be effective to achieve insurance market reform and expand coverage to new enrollees.
Experimental Drug Gains FDA Orphan Drug Designation for Glioblastoma
GDC-0084 is a small molecule inhibitor of phosphatidylinositol 3-kinase with potential antineoplastic activity.
